FDA approved Moderna’s mRNA RSV vaccine mRESVIA for older adults
Dated 31 May 2024: FDA approved Moderna’s mRNA RSV vaccine mRESVIA for older adults. In the causal graph this event strengthens the driver mRNA-Platform Development.
Who was responsible
Contribution type and responsibility level for each recorded actor — not sole-author shorthand.
No public contributors are listed for this fact.
What changed
Fact → Driver → Indicator. Relationship strength orders the paths; it is not the observed indicator movement.
- FactFDA approved Moderna’s mRNA RSV vaccine mRESVIA for older adults
- strengthensDrivermRNA-Platform Development
provisional weight · verified
Causal path
How this event connects to drivers and indicators in the graph.
- FactFDA approved Moderna’s mRNA RSV vaccine mRESVIA for older adults
- strengthensDrivermRNA-Platform Development
Cite this page
Factrail. (2026). FDA approved Moderna’s mRNA RSV vaccine mRESVIA for older adults. Factrail. https://factrail.ai/facts/fda-mresvia-rsv-mrna-vaccine-approval-2024
https://factrail.ai/facts/fda-mresvia-rsv-mrna-vaccine-approval-2024
Accessed 15 October 2026.
By the Factrail desk · Method: how we source and score · Last reviewed
Dispute this factNamed here, or represent someone who is? Request a right of reply.